多囊卵巢综合征胰岛素抵抗及高雄激素血症的治疗(2)
[3] 林金芳,李昕,苏椿淋.多囊卵巢综合征患者胰岛素抵抗的诊断方法及治疗策略.中国实用妇科与产科杂志,2007,23(9):665.
[4] Sangraula H, Paudel KR, Sharma M. Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome. JNMA J Nepal Med Assoc, 2009 , 48(176):335-9.
[5] Ghazeeri GS, Nassar AH, Younes Z, et al. Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview. Acta Obstet Gynecol Scand, 2012 , 91(6):658-78.
[6] Tang T, Lord JM, Norman RJ, et a1.Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev, 2012 , 5: CD003053.
[7] 王力, 闻姬, 崔薇, 孙伟. 不同促排卵方案在多囊卵巢综合征患者IVF-ET治疗中的应用分析. 现代妇产科进展.2011,20(4):283-285.
[8] Baptiste CG, Battista MC, et al. Trottier A, Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol, 2010 , 122(1-3):42-52.
[9] Bargiota A, Diamanti-Kandarakis E. The effects of old, new and emerging medicines on metabolic aberrations in PCOS. Ther Adv Endocrinol Metab, 2012 , 3(1):27-47., 百拇医药(桑敏 胡敏 吴效科)
[4] Sangraula H, Paudel KR, Sharma M. Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome. JNMA J Nepal Med Assoc, 2009 , 48(176):335-9.
[5] Ghazeeri GS, Nassar AH, Younes Z, et al. Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview. Acta Obstet Gynecol Scand, 2012 , 91(6):658-78.
[6] Tang T, Lord JM, Norman RJ, et a1.Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev, 2012 , 5: CD003053.
[7] 王力, 闻姬, 崔薇, 孙伟. 不同促排卵方案在多囊卵巢综合征患者IVF-ET治疗中的应用分析. 现代妇产科进展.2011,20(4):283-285.
[8] Baptiste CG, Battista MC, et al. Trottier A, Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol, 2010 , 122(1-3):42-52.
[9] Bargiota A, Diamanti-Kandarakis E. The effects of old, new and emerging medicines on metabolic aberrations in PCOS. Ther Adv Endocrinol Metab, 2012 , 3(1):27-47., 百拇医药(桑敏 胡敏 吴效科)